Literature DB >> 10618409

A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.

P L Herrera1, D M Harlan, P Vassalli.   

Abstract

Double transgenic mice [rat insulin promoter (RIP)-tumor necrosis factor (TNF) and RIP-CD80] whose pancreatic beta cells release TNF and bear CD80 all develop an acute early (6 wk) and lethal diabetes mediated by CD8 T cells. The first ultrastructural changes observed in beta cells, so far unreported, are focal lesions of endoplasmic reticulum swelling at the points of contact with islet-infiltrating lymphoblasts, followed by cytoplasmic, but not nuclear, apoptosis. Such double transgenic mice were made defective in either the perforin, Fas, or TNF pathways. Remarkably, diabetes was found to be totally independent of perforin and Fas. Mice lacking TNF receptor (TNFR) II had no or late diabetes, but only a minority had severe insulitis. Mice lacking the TNF-lymphotoxin (LTalpha) locus (whose sole source of TNF are the beta cells) all had insulitis comparable to that of nondefective mice, but no diabetes or a retarded and milder form, with lesions suggesting different mechanisms of injury. Because both TNFR II and TNF-LTalpha mutations have complex effects on the immune system, these data do not formally incriminate membrane TNF as the major T cell mediator of this acute autoimmune diabetes; nevertheless, in the absence of involvement of the perforin or Fas cytotoxic pathways, membrane TNF appears to be the likeliest candidate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618409      PMCID: PMC26654          DOI: 10.1073/pnas.97.1.279

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation.

Authors:  A C Loweth; G T Williams; R F James; J H Scarpello; N G Morgan
Journal:  Diabetes       Date:  1998-05       Impact factor: 9.461

Review 2.  Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?

Authors:  J I Reimers
Journal:  Dan Med Bull       Date:  1998-04

Review 3.  CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families.

Authors:  H Donner; C Seidl; J Braun; T Siegmund; J Herwig; E Seifried; K H Usadel; K Badenhoop
Journal:  Diabetes       Date:  1998-07       Impact factor: 9.461

4.  Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.

Authors:  M Grell; G Zimmermann; E Gottfried; C M Chen; U Grünwald; D C Huang; Y H Wu Lee; H Dürkop; H Engelmann; P Scheurich; H Wajant; A Strasser
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

5.  Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.

Authors:  M Woo; R Hakem; M S Soengas; G S Duncan; A Shahinian; D Kägi; A Hakem; M McCurrach; W Khoo; S A Kaufman; G Senaldi; T Howard; S W Lowe; T W Mak
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

6.  The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.

Authors:  M Grell; H Wajant; G Zimmermann; P Scheurich
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.

Authors:  H Donner; J Braun; C Seidl; H Rau; R Finke; M Ventz; P G Walfish; K H Usadel; K Badenhoop
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

8.  Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.

Authors:  T Awata; S Kurihara; M Iitaka; S Takei; I Inoue; C Ishii; K Negishi; T Izumida; Y Yoshida; R Hagura; N Kuzuya; Y Kanazawa; S Katayama
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

9.  Regulation of MHC protein expression in pancreatic beta-cells by interferon-gamma and tumor necrosis factor-alpha.

Authors:  I L Campbell; L Oxbrow; J West; L C Harrison
Journal:  Mol Endocrinol       Date:  1988-02

10.  Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.

Authors:  D Kägi; B Odermatt; P Seiler; R M Zinkernagel; T W Mak; H Hengartner
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

View more
  9 in total

1.  Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation.

Authors:  Justin Kline; Long Zhang; Lauren Battaglia; Kenneth S Cohen; Thomas F Gajewski
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

Review 2.  TNF activity and T cells.

Authors:  Amit K Mehta; Donald T Gracias; Michael Croft
Journal:  Cytokine       Date:  2016-08-13       Impact factor: 3.861

3.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 4.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

5.  Macrophage polarization is linked to Ca2+-independent phospholipase A2β-derived lipids and cross-cell signaling in mice.

Authors:  Alexander J Nelson; Daniel J Stephenson; Christopher L Cardona; Xiaoyong Lei; Abdulaziz Almutairi; Tayleur D White; Ying G Tusing; Margaret A Park; Suzanne E Barbour; Charles E Chalfant; Sasanka Ramanadham
Journal:  J Lipid Res       Date:  2019-12-09       Impact factor: 5.922

6.  Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

Review 7.  The Impact of the Ca2+-Independent Phospholipase A2β (iPLA2β) on Immune Cells.

Authors:  Tayleur D White; Abdulaziz Almutairi; Ying Gai Tusing; Xiaoyong Lei; Sasanka Ramanadham
Journal:  Biomolecules       Date:  2021-04-15

8.  Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study.

Authors:  Lucy Mastrandrea; Jihnhee Yu; Torsten Behrens; John Buchlis; Christine Albini; Shannon Fourtner; Teresa Quattrin
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 19.112

Review 9.  A New Venue of TNF Targeting.

Authors:  Sophie Steeland; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.